ARCHIVES

BMS Control Of Billion-Dollar Taxol Market Facing Court Challeges By Competitors

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

Gene Therapy Alters Immune Cells For Treatment Of Advanced Melanoma

September 29, 2006

NCI Launches Effort In Cancer Education For Older Americans; Also An ACS Goal, Dodd Tells Writers

March 29, 1991

Calcium, Vitamin D Provide No Benefit for Colon Cancer

February 24, 2006

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

In Brief: Visco Elected Chairman of DOD Panel; Breast Cancer Stamp Raises $4.9 Million

February 19, 1999